Mersana Therapeutics Inc (MRSN) support and resistance · rev $40.5M
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
This page maps Mersana Therapeutics Inc (MRSN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
MRSN currently screens at market cap $145.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MRSN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MRSN quote page for the session range and the stock page for the full model.
Not investment advice.